Lineage Cell Therapeutics, Inc. (LCTX): Price and Financial Metrics
LCTX Price/Volume Stats
| Current price | $1.03 | 52-week high | $1.15 |
| Prev. close | $1.02 | 52-week low | $0.37 |
| Day low | $0.99 | Volume | 1,045,800 |
| Day high | $1.03 | Avg. volume | 1,972,162 |
| 50-day MA | $0.72 | Dividend yield | N/A |
| 200-day MA | $0.66 | Market Cap | 235.21M |
LCTX Stock Price Chart Interactive Chart >
Lineage Cell Therapeutics, Inc. (LCTX) Company Bio
Lineage Cell Therapeutics, Inc. operates as a biotechnology company. The Company offers cell-based therapies and gene marker-based molecular diagnostics for diseases and degenerative conditions. Lineage Cell Therapeutics serves patients in the United States.
LCTX Price Returns
| 1-mo | 46.62% |
| 3-mo | 119.24% |
| 6-mo | 72.01% |
| 1-year | 1.98% |
| 3-year | -36.42% |
| 5-year | 34.99% |
| YTD | 104.98% |
| 2024 | -53.90% |
| 2023 | -6.84% |
| 2022 | -52.24% |
| 2021 | 39.20% |
| 2020 | 97.75% |
Loading social stream, please wait...